scorecardresearch
Follow Us:
Friday, May 27, 2022

WHO-led Covax vaccine scheme agrees to new supply deal with Serum Institute of India

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.

By: Reuters |
February 3, 2021 10:08:22 pm
European union, covid vaccine

India’s Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the U.N. Children’s Fund said on Wednesday.

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries. They would be produced by Serum under a technology transfer agreement, she said in a briefing.

The COVAX facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and UNICEF.

Best of Express Premium

UPSC Key – May 27, 2022: Why and What to know about Lieutenant Governor t...Premium
Anek movie review: Ayushmann Khurrana, Andrea film swings between convict...Premium
NAS 2021: Punjab schools outshine Delhi, reignite debate over better educ...Premium
Hard life of the ever-smiling cricketer Rinku Singh, KKR’s rising starPremium

For all the latest World News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement